The rounds this investor is named on, who it invests beside, and where it shows up.
Named on one round in the feed.
Hatteras Venture Partners is a venture capital firm that builds transformational companies in areas of health innovation.
Venture capitalhatterasvp.comSince 2025-04-02
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Atsena Therapeutics Atsena Therapeutics develops gene therapies for inherited retinal diseases, targeting conditions like X-linked retinoschisis and Leber congenital amaurosis. | Series C Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $150M | 2025-04-02 | [ PART ] |